0000021665-24-000044 | 10-Q | XBRL Viewer

$ 1,695

1,582

113

^[1]

(44)

^[2]

(1,584)

(59)

145

152

(30)

(883)

Ending balance at Sep. 30, 2023

(5)

1,466

3,762

(25,834)

24,571

(3,974)

^[1],[3]

415

Beginning balance at Jun. 30, 2023

1,466

3,688

(25,541)

24,258

(3,935)

^[3]

379

747

708

(42)

(39)

^[3]

(3)

(395)

(16)

(332)

Ending balance at Sep. 30, 2023

(2)

1,466

3,762

(25,834)

24,571

(3,974)

^[1],[3]

415

Beginning balance at Dec. 31, 2023

957

1,466

3,808

(26,017)

25,289

(3,937)

348

2,270

2,150

120

(141)

(136)

(5)

(1,625)

(63)

108

273

337

(51)

(1,284)

Ending balance at Sep. 30, 2024

(1)

836

1,466

4,142

(26,913)

25,814

(4,074)

^[3]

401

Beginning balance at Jun. 30, 2024

1,466

4,035

(26,736)

25,486

(4,128)

^[3]

359

776

737

^[3]

(409)

(29)

(295)

Ending balance at Sep. 30, 2024

(1)

$ 836

$ 1,466

$ 4,142

$ 0

$ (26,913)

$ 25,814

$ (4,074)

^[3]

$ 401

[1]	Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,515 at September 30, 2024 ($3,458 at September 30, 2023) and $3,351 at December 31, 2023 ($3,491 at December 31, 2022), respectively, and unrecognized retirement plan and other retiree benefits costs of $615 at September 30, 2024 ($586 at September 30, 2023) and $647 at December 31, 2023 ($631 at December 31, 2022), respectively.
[2]	Two dividends were declared in each of the first quarters of 2024 and 2023.
[3]	Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,515 at September 30, 2024 ($3,458 at September 30, 2023) and $3,555 at June 30, 2024 ($3,381 at June 30, 2023), respectively, and unrecognized retirement plan and other retiree benefits costs of $615 at September 30, 2024 ($586 at September 30, 2023) and $636 at June 30, 2024 ($618 at June 30, 2023), respectively.

Fair Value Measurements and Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2024

Fair Value Disclosures [Abstract]

Schedule of Fair Value of Derivative Instruments and Other Financial Instruments

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Condensed Consolidated Balance Sheets at September 30, 2024 and December 31, 2023:


	Assets					Liabilities
	Account	Fair Value					Account		Fair Value
Designated derivative instruments		September 30, 2024		December 31, 2023						September 30, 2024		December 31, 2023




Foreign currency contracts	Other current assets	$	31	$	19			Other accruals		$	39	$	25

Commodity contracts	Other current assets	—		—				Other accruals		1		1
Total designated		$	31	$	19					$	40	$	26

Other financial instruments
Marketable securities	Other current assets	$	260	$	179
Total other financial instruments		$	260	$	179

Schedule of Notional Values

The following tables present the notional values as of:


	September 30, 2024
	Foreign Currency Contracts		Foreign Currency Debt		Commodity Contracts		Total
Fair Value Hedges	$	1,732	$	—	$	—	$	1,732
Cash Flow Hedges	1,022		—		26		1,048
Net Investment Hedges	474		4,269		—		4,743


	December 31, 2023
	Foreign Currency Contracts		Foreign Currency Debt		Commodity Contracts		Total
Fair Value Hedges	$	1,625	$	—	$	—	$	1,625
Cash Flow Hedges	869		—		39		908
Net Investment Hedges	280		3,908		—		4,188

Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)

The following table presents the amount of gain (loss) on net investment hedges recognized in the Company’s AOCI:


	Gain (Loss) Recognized in AOCI
	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Hedging instruments:
Foreign currency contracts	$	(4)	$	(37)	$	20	$	(19)
Foreign currency debt	(216)		50		(82)		90
Total gain (loss) on net investment hedges	$	(220)	$	13	$	(62)	$	71

Recent Accounting Pronouncements and Disclosure Rules	9 Months Ended
Recent Accounting Pronouncements and Disclosure Rules	Sep. 30, 2024
Accounting Standards Update and Change in Accounting Principle [Abstract]
Recent Accounting Pronouncements and Disclosure Rules	Recent Accounting Pronouncements and Disclosure Rules In March 2024, the SEC finalized rules intended to enhance and standardize climate-related disclosures in registrants’ registration statements and Annual Reports on Form 10-K. The new rules would require climate-related disclosures, including as they relate to governance, strategy, risk management, targets and goals and greenhouse gas emissions. In addition, the rules would require certain climate-related disclosures as it relates to severe weather events and other natural conditions and carbon offsets and renewable energy credits. In April 2024, the SEC voluntarily stayed the rules due to pending judicial review. As these rules only impact disclosures, they will not have a material impact on the Company’s Consolidated Financial Statements. In December 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU improves the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the rate reconciliation, and income taxes paid disaggregated by jurisdiction. This guidance is effective for the Company for fiscal years beginning after December 15, 2024. As this accounting standard only impacts disclosures, it will not have a material impact on the Company’s Consolidated Financial Statements. In December 2023, the FASB issued ASU No. 2023-08, “Intangibles-Goodwill and Other-Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets.” This ASU improves the accounting for certain crypto assets by requiring companies to measure them at fair value for each reporting period with changes in fair value recognized in net income. This guidance is effective for the Company for fiscal years beginning after December 15, 2024 and is not expected to have an impact on the Company’s Consolidated Financial Statements. In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU modified the disclosure and presentation requirements primarily through enhanced disclosures of significant segment expenses and other segment items. This guidance is effective for the Company for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. As this accounting standard only impacts disclosures, it will not have a material impact on the Company’s Consolidated Financial Statements. In October 2023, the FASB issued ASU No. 2023-06, “Disclosure Improvements-Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.” This ASU modified the disclosure and presentation requirements of a variety of codification topics by aligning them with the SEC’s regulations. This guidance is effective for the Company no later than June 30, 2027. As this accounting standard only impacts disclosures, it will not have a material impact on the Company’s Consolidated Financial Statements. In August 2023, the FASB issued ASU No. 2023-05, “Business Combinations-Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement.” This ASU requires a joint venture to initially measure all contributions received upon its formation at fair value. This guidance is applicable to joint ventures with a formation date on or after January 1, 2025 and is not expected to have a material impact on the Company’s Consolidated Financial Statements. In March 2023, the FASB issued ASU No. 2023-01, “Leases (Topic 842): Common Control Arrangements.” This ASU clarified the accounting for leasehold improvements for leases under common control. The guidance was effective for the Company beginning on January 1, 2024 and did not have a material impact on the Company’s Consolidated Financial Statements. In September 2022, the FASB issued ASU No. 2022-04, “Liabilities-Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” This ASU requires a buyer that uses supplier finance programs to make annual disclosures about the programs’ key terms, the balance sheet presentation of related amounts, the confirmed amount outstanding at the end of the period and associated roll-forward information. The Company adopted the guidance beginning on January 1, 2023, and with respect to the roll-forward information disclosure, beginning on January 1, 2024. See Note 12, Supplier Finance Program for additional information.

The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476173/280-10-65-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-7

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SAB Topic 11.M.Q2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480530/250-10-S99-5

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (i)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480528/815-20-65-6

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479654/326-10-65-4

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479654/326-10-65-4

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 926
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483194/926-20-65-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 926
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483194/926-20-65-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 926
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (f)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483194/926-20-65-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480530/250-10-S99-6

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 250
-Publisher FASB
-URI https://asc.fasb.org/250/tableOfContent

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Schedule of Net Sales and Operating Profit by Segment

Restructuring and Related Implementation Charges - Schedule of Restructuring Activity and Related Accruals (Details) - Global Productivity Initiative $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($)
Restructuring Reserve [Roll Forward]
Balance	$ 11
Charges	77
Cash Payments	(23)
Charges against assets	(13)
Foreign exchange	(1)
Balance	51
Employee-Related Costs
Restructuring Reserve [Roll Forward]
Balance	10
Charges	49
Cash Payments	(13)
Charges against assets	0
Foreign exchange	(1)
Balance	45
Incremental Depreciation
Restructuring Reserve [Roll Forward]
Balance	0
Charges	13
Cash Payments	0
Charges against assets	(13)
Foreign exchange	0
Balance	0
Asset Impairments
Restructuring Reserve [Roll Forward]
Balance	0
Charges	0
Cash Payments	0
Charges against assets	0
Foreign exchange	0
Balance	0
Other
Restructuring Reserve [Roll Forward]
Balance	1
Charges	15
Cash Payments	(10)
Charges against assets	0
Foreign exchange	0
Balance	$ 6

Use of Estimates	9 Months Ended
Use of Estimates	Sep. 30, 2024
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.

Segment Information (Tables)

9 Months Ended

Sep. 30, 2024

Segment Reporting [Abstract]

Net sales by segment were as follows:


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2024		2023		2024		2023
Net sales
Oral, Personal and Home Care
North America	$	1,004	$	1,025	$	3,076	$	3,044
Latin America	1,156		1,194		3,676		3,447
Europe	744		690		2,102		1,935
Asia Pacific	725		682		2,133		2,084
Africa/Eurasia	278		266		827		822
Total Oral, Personal and Home Care	3,907		3,857		11,814		11,332
Pet Nutrition	1,126		1,058		3,342		3,175
Total Net sales	$	5,033	$	4,915	$	15,156	$	14,507

The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2024		2023		2024		2023
Net sales
Oral Care	44	%	43	%	43	%	42	%
Personal Care	18	%	19	%	18	%	19	%
Home Care	16	%	17	%	17	%	17	%
Pet Nutrition	22	%	21	%	22	%	22	%
Total Net sales	100	%	100	%	100	%	100	%

Operating profit by segment was as follows:


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2024		2023		2024		2023
Operating profit
Oral, Personal and Home Care
North America	$	206	$	227	$	633	$	640
Latin America	365		372		1,187		1,050
Europe	181		165		502		422
Asia Pacific	199		193		602		564
Africa/Eurasia	65		66		195		196
Total Oral, Personal and Home Care	1,016		1,024		3,119		2,873
Pet Nutrition	258		201		691		575
Corporate	(208)		(196)		(605)		(536)
Total Operating profit	$	1,065	$	1,029	$	3,205	$	2,912

Note: Table may not sum due to rounding.

Fair Value Measurements and Financial Instruments - Schedule of Fair Value of Derivative Instruments and Other Financial Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Designated derivative instruments
Derivative assets	$ 31	$ 19
Derivative liabilities	$ 40	$ 26
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Other accruals	Other accruals
Other financial instruments
Total other financial instruments	$ 260	$ 179
Foreign currency contracts
Designated derivative instruments
Derivative assets	31	19
Derivative liabilities	39	25
Commodity contracts
Designated derivative instruments
Derivative assets	0	0
Derivative liabilities	1	1
Other current assets
Other financial instruments
Marketable securities	$ 260	$ 179

Segment Information - Schedule of Net Sales and Operating Profit by Segment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Total Net sales	$ 5,033	$ 4,915	$ 15,156	$ 14,507
Operating profit (loss)	$ 1,065	$ 1,029	$ 3,205	$ 2,912
Product Concentration Risk \| Net Sales
Segment Reporting Information [Line Items]
Percent of net sales	100.00%	100.00%	100.00%	100.00%
Product Concentration Risk \| Net Sales \| Oral Care
Segment Reporting Information [Line Items]
Percent of net sales	44.00%	43.00%	43.00%	42.00%
Product Concentration Risk \| Net Sales \| Personal Care
Segment Reporting Information [Line Items]
Percent of net sales	18.00%	19.00%	18.00%	19.00%
Product Concentration Risk \| Net Sales \| Home Care
Segment Reporting Information [Line Items]
Percent of net sales	16.00%	17.00%	17.00%	17.00%
Product Concentration Risk \| Net Sales \| Pet Nutrition
Segment Reporting Information [Line Items]
Percent of net sales	22.00%	21.00%	22.00%	22.00%
Operating Segments \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Total Net sales	$ 3,907	$ 3,857	$ 11,814	$ 11,332
Operating profit (loss)	1,016	1,024	3,119	2,873
Operating Segments \| Pet Nutrition
Segment Reporting Information [Line Items]
Total Net sales	1,126	1,058	3,342	3,175
Operating profit (loss)	258	201	691	575
Operating Segments \| North America \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Total Net sales	1,004	1,025	3,076	3,044
Operating profit (loss)	206	227	633	640
Operating Segments \| Latin America \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Total Net sales	1,156	1,194	3,676	3,447
Operating profit (loss)	365	372	1,187	1,050
Operating Segments \| Europe \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Total Net sales	744	690	2,102	1,935
Operating profit (loss)	181	165	502	422
Operating Segments \| Asia Pacific \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Total Net sales	725	682	2,133	2,084
Operating profit (loss)	199	193	602	564
Operating Segments \| Africa/Eurasia \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Total Net sales	278	266	827	822
Operating profit (loss)	65	66	195	196
Corporate
Segment Reporting Information [Line Items]
Operating profit (loss)	$ (208)	$ (196)	$ (605)	$ (536)

Restructuring and Related Implementation Charges - Schedule of Restructuring and Related Costs (Details) - Global Productivity Initiative - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]
Total 2022 Global Productivity Initiative charges, pretax	$ 15	$ 2	$ 77	$ 29
Total 2022 Global Productivity Initiative charges, aftertax	$ 13	$ 2	67	23
Gross Profit
Restructuring Cost and Reserve [Line Items]
Total 2022 Global Productivity Initiative charges, pretax			19	1
Selling, general and administrative expenses
Restructuring Cost and Reserve [Line Items]
Total 2022 Global Productivity Initiative charges, pretax			4	2
Other (income) expense, net
Restructuring Cost and Reserve [Line Items]
Total 2022 Global Productivity Initiative charges, pretax			54	22
Non-service related postretirement costs
Restructuring Cost and Reserve [Line Items]
Total 2022 Global Productivity Initiative charges, pretax			$ 0	$ 4

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss) Attributable to Parent	$ 737	$ 708	$ 2,150	$ 1,582

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-6

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-10

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479105/946-220-45-7

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B

Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income including noncontrolling interests	$ 776	$ 747	$ 2,270	$ 1,695
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments	44	(79)	(168)	(9)
Retirement plans and other retiree benefit adjustments	21	32	32	45
Gains (losses) on cash flow hedges	(7)	5	(5)	1
Total Other comprehensive income (loss), net of tax	58	(42)	(141)	37
Total Comprehensive income including noncontrolling interests	834	705	2,129	1,732
Less: Net income attributable to noncontrolling interests	39	39	120	113
Less: Cumulative translation adjustments attributable to noncontrolling interests	3	(3)	(5)	(44)
Total Comprehensive income attributable to noncontrolling interests	42	36	115	69
Total Comprehensive income attributable to Colgate-Palmolive Company	$ 792	$ 669	$ 2,014	$ 1,663

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The effective income tax rate was 21.3% for the third quarter of 2024 as compared to 21.9% for the third quarter of 2023. The quarterly provision for income taxes is determined based on the Company’s estimated full year effective income tax rate adjusted by the amount of tax attributable to infrequent or unusual items that are separately recognized on a discrete basis in the income tax provision in the quarter in which they occur. The Company’s current estimate of its full year effective income tax rate before discrete period items is 23.7%, flat with the comparable period of 2023. In the third quarter of 2023, the Internal Revenue Service (the “IRS”) issued a notice giving taxpayers temporary relief from the effects of certain U.S. tax regulations that were issued in December 2021, which place greater restrictions on foreign taxes that are creditable against U.S. taxes on foreign-source income. This notice allowed taxpayers to defer the application of these new regulations through the end of 2023. In December 2023, the IRS issued further guidance modifying this temporary relief period to the date that a notice or other guidance withdrawing or modifying the temporary relief is issued. The Company will recognize the impact, if any, in the period in which the temporary relief is withdrawn or modified. The Company has ongoing federal, state and international income tax audits in various jurisdictions and evaluates uncertain tax positions that may be challenged by local tax authorities and not fully sustained. All U.S. federal income tax returns through December 31, 2013 have been audited by the IRS and there are limited matters which the Company plans to appeal for years 2010 through 2013. One such matter relates to the IRS assessment of taxes on the Company by imputing income on certain activities within one of our international operations, which is also under audit for the years 2014 through 2018. There were U.S. Tax Court rulings during 2023 in favor of the IRS against unrelated third parties on similar matters. Despite the U.S. Tax Court rulings, the Company continues to believe that the tax assessment against the Company is without merit. While there can be no assurances, the Company believes this matter will ultimately be decided in favor of the Company. The amount of tax plus interest for the years 2010 through 2018 is estimated to be approximately $150, which is not included in the Company’s uncertain tax positions. In May 2024, the IRS initiated an audit for the years 2019 through 2021. On August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was enacted, which among other things, implements a 15% minimum tax on book income of certain large corporations effective for years beginning after December 31, 2022. Based on the Company’s analysis, as well as guidance published by the IRS, the IRA, and in particular the 15% minimum tax, did not have an impact on the Company’s Consolidated Financial Statements. Subsequent to the aforementioned guidance published by the IRS, on September 12, 2024, the U.S. Treasury Department and IRS released proposed regulations relating to this 15% minimum tax. The Company is currently evaluating the potential impact of these regulations and will evaluate any additional guidance and clarification that becomes available. Additionally, on December 15, 2022, the 27 member states of the European Union (“EU”) reached an agreement on a minimum level of taxation for certain large corporations to pay a minimum corporate tax rate of 15% in every jurisdiction in which they operate. This agreement, which is known as the Minimum Tax Directive (part of the “Pillar II Model Rules”), was supposed to be transposed into the laws of all EU member states by December 31, 2023. Most member states complied, while some were granted extensions of time. In addition, many other jurisdictions outside the EU have also committed to implement this Directive while others have implemented a similar minimum tax regime consistent with the policy of the Pillar II Model Rules. Details of these rules are still being developed and, in some cases, enactment and timing is still uncertain. Based on current legislation and available guidance, this Directive does not have a material impact on the Company’s Consolidated Financial Statements. However, as these rules and related regulations are revised and implemented, the Company will evaluate the impact, if any, on its Consolidated Financial Statements. During the quarter ended June 30, 2023, the Company reassessed with its legal and tax advisers certain tax deductions taken in prior years by one of our subsidiaries and concluded that it was more likely than not that the deductions would not be sustained by the courts in that jurisdiction. The value of the tax deductions was not material to the Company in any year in which they were taken. The cumulative effect of the change in tax position of $148 was reflected as a discrete item in the quarter ended June 30, 2023 income tax expense, partially offset by the reversal of certain prior years’ withholding tax reserves of $22 that were no longer required. The tax liability was paid in the quarter ended September 30, 2023.

The entire disclosure for income tax.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477891/740-270-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-13

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/740/tableOfContent

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-14

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-21

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-17

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482603/740-30-50-2

Schedule of Components of Net Periodic Benefit Cost

Restructuring and Related Implementation Charges - Narrative (Details) - Global Productivity Initiative - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Jan. 27, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring program cost before tax	$ 225,000,000		$ 225,000,000
Restructuring program cost, after tax	180,000,000		$ 180,000,000
Restructuring and related cost, estimated to settle through cash, percentage					80.00%
Percent of total restructuring charges related to segment			100.00%	100.00%
Total 2022 Global Productivity Initiative charges, pretax	15,000,000	$ 2,000,000	$ 77,000,000	$ 29,000,000
Total 2022 Global Productivity Initiative charges, aftertax	$ 13,000,000	$ 2,000,000	67,000,000	$ 23,000,000
Employee related costs include pension			$ 0
Hill's Pet Nutrition
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment			7.00%	14.00%
Corporate
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment			2.00%	20.00%
North America
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment			3.00%	15.00%
Latin America
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment			0.00%	1.00%
Europe
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment			88.00%	19.00%
Asia Pacific
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment			0.00%	21.00%
Africa/Eurasia
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment			0.00%	10.00%
Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost, percentage					80.00%
Asset Related Costs
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost, percentage					5.00%
Other
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost, percentage					15.00%

Inventories - Schedule of Inventories by Major Class (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Raw materials and supplies	$ 620	$ 606
Work-in-process	49	46
Finished goods	1,489	1,411
Total Inventories, net	2,158	2,063
Non-current inventory, net	(117)	(129)
Current Inventories, net	$ 2,041	$ 1,934

Retirement Plans and Other Retiree Benefits (Tables)

9 Months Ended

Sep. 30, 2024

Retirement Benefits [Abstract]

Components of Net periodic benefit cost for the three and nine months ended September 30, 2024 and 2023 were as follows:


	Three Months Ended September 30,
	Pension Benefits								Other Retiree Benefits
	United States				International
	2024		2023		2024		2023		2024		2023
Service cost	$	1	$	—	$	3	$	3	$	2	$	2
Interest cost	23		20		7		6		8		7
Expected return on plan assets	(20)		(20)		(7)		(5)		—		—
Amortization of actuarial losses (gains)	10		12		2		1		(5)		(6)
Net periodic benefit cost	$	14	$	12	$	5	$	5	$	5	$	3
Other postretirement charges	5		—		—		—		—		—


Total pension cost	$	19	$	12	$	5	$	5	$	5	$	3


	Nine Months Ended September 30,
	Pension Benefits								Other Retiree Benefits
	United States				International

	2024		2023		2024		2023		2024		2023
Service cost	$	1	$	—	$	11	$	9	$	6	$	6
Interest cost	70		68		22		22		26		29
Expected return on plan assets	(58)		(61)		(20)		(14)		—		—

Amortization of actuarial losses (gains)	31		34		4		3		(13)		(14)
Net periodic benefit cost	$	44	$	41	$	17	$	20	$	19	$	21
Other postretirement charges	5		4		—		—		—		—
ERISA litigation matter	—		267		—		—		—		—
Total pension cost	$	49	$	312	$	17	$	20	$	19	$	21

Inventories

9 Months Ended

Sep. 30, 2024

Inventory, Net, Items Net of Reserve Alternative [Abstract]

Inventories

Inventories by major class were as follows:


	September 30, 2024		December 31, 2023
Raw materials and supplies	$	620	$	606
Work-in-process	49		46
Finished goods	1,489		1,411
Total Inventories, net	$	2,158	$	2,063
Non-current inventory, net	(117)		(129)
Current Inventories, net	$	2,041	$	1,934

Restructuring and Related Implementation Charges (Tables)

9 Months Ended

Sep. 30, 2024

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Costs

For the nine months ended September 30, 2024 and September 30, 2023, charges resulting from the 2022 Global Productivity Initiative are reflected in the income statement as follows:


	Nine Months Ended September 30,
	2024		2023
Gross Profit	$	19	$	1
Selling, general and administrative expenses	4		2
Other (income) expense, net	54		22
Non-service related postretirement costs	—		4
Total 2022 Global Productivity Initiative charges, pretax	$	77	$	29

Total 2022 Global Productivity Initiative charges, aftertax	$	67	$	23

The following table summarizes the activity for the restructuring and related implementation charges discussed above and the related accruals:


	Nine Months Ended September 30, 2024
	Employee-Related Costs		Incremental Depreciation		Asset Impairments		Other		Total
Balance at December 31, 2023	$	10	$	—	$	—	$	1	$	11
Charges	49		13		—		15		77
Cash Payments	(13)		—		—		(10)		(23)
Charges against assets	—		(13)		—		—		(13)
Foreign exchange	(1)		—		—		—		(1)
Balance at September 30, 2024	$	45	$	—	$	—	$	6	$	51

Schedule of Percent of Total Restructuring Charges Related To Segment for the period

Total charges incurred for the 2022 Global Productivity Initiative relate to initiatives undertaken by the following reportable operating segments and Corporate:


	Nine Months Ended September 30,				Program-to-date Accumulated Charges
	2024		2023
North America(1)	3	%	15	%	9	%
Latin America	—	%	1	%	9	%
Europe(1)	88	%	19	%	43	%
Asia Pacific	—	%	21	%	7	%
Africa/Eurasia	—	%	10	%	6	%
Hill's Pet Nutrition	7	%	14	%	12	%
Corporate	2	%	20	%	14	%
Total	100	%	100	%	100	%

(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024. The results of the skin health business previously reported within the Europe reportable operating segment are reported with the other skin health businesses in the North America reportable operating segment. See Note 10, Segment Information for additional details.

Schedule of Cumulative Pretax Restructuring Charges

Since the inception of the 2022 Global Productivity Initiative, the Company has incurred cumulative pretax charges of $220 ($178 aftertax) in connection with the implementation of various projects as follows:


	Cumulative Charges
	as of September 30, 2024
Employee-Related Costs	$	175
Incremental Depreciation	13
Asset Impairments	1
Other	31
Total	$	220

Condensed Consolidated Statements of Changes in Shareholders’ Equity (Parenthetical) $ in Millions	3 Months Ended				9 Months Ended
	Sep. 30, 2024 USD ($) $ / shares	Mar. 31, 2024 dividend	Sep. 30, 2023 USD ($) $ / shares	Mar. 31, 2023 dividend	Sep. 30, 2024 USD ($) $ / shares	Sep. 30, 2023 USD ($) $ / shares	Jun. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)	Jun. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Statement of Stockholders' Equity [Abstract]
Dividends declared per common share (in dollars per share) \| $ / shares	$ 0.50		$ 0.48		$ 1.98	$ 1.91
Accumulated other comprehensive loss, cumulative translation losses	$ 3,515		$ 3,458		$ 3,515	$ 3,458	$ 3,555	$ 3,351	$ 3,381	$ 3,491
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs	$ 615		$ 586		$ 615	$ 586	$ 636	$ 647	$ 618	$ 631
Number of dividends declared per quarter \| dividend		2		2

Restructuring and Related Implementation Charges - Schedule of Restructuring Charges, Cumulative to Date (Details) - Global Productivity Initiative $ in Millions	Sep. 30, 2024 USD ($)
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the restructuring program to date	$ 220
Restructuring and related cost incurred cost to date after tax	178
Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the restructuring program to date	175
Incremental Depreciation
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the restructuring program to date	13
Asset Impairments
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the restructuring program to date	1
Other
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the restructuring program to date	$ 31

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Retirement Plans and Other Retiree Benefits - Schedule of Components of Net Periodic Benefit Cost (Details) - USD ($)	3 Months Ended			9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Components of net periodic benefit cost
ERISA litigation matter			$ 267,000,000	$ 0	$ 267,000,000
Employee-Related Costs \| Global Productivity Initiative
Components of net periodic benefit cost
Other postretirement charges		$ 0			4,000,000
Other Retiree Benefits
Components of net periodic benefit cost
Service cost	$ 2,000,000	2,000,000		6,000,000	6,000,000
Interest cost	8,000,000	7,000,000		26,000,000	29,000,000
Expected return on plan assets	0	0		0	0
Amortization of actuarial losses (gains)	(5,000,000)	(6,000,000)		(13,000,000)	(14,000,000)
Net periodic benefit cost	5,000,000	3,000,000		19,000,000	21,000,000
Other postretirement charges	0	0		0	0
ERISA litigation matter				0	0
Total pension cost	5,000,000	3,000,000		19,000,000	21,000,000
United States \| Pension Benefits
Components of net periodic benefit cost
Service cost	1,000,000	0		1,000,000	0
Interest cost	23,000,000	20,000,000		70,000,000	68,000,000
Expected return on plan assets	(20,000,000)	(20,000,000)		(58,000,000)	(61,000,000)
Amortization of actuarial losses (gains)	10,000,000	12,000,000		31,000,000	34,000,000
Net periodic benefit cost	14,000,000	12,000,000		44,000,000	41,000,000
Other postretirement charges	5,000,000	0		5,000,000	4,000,000
ERISA litigation matter				0	267,000,000
Total pension cost	19,000,000	12,000,000		49,000,000	312,000,000
Voluntary benefit plan contribution	0	0
International \| Pension Benefits
Components of net periodic benefit cost
Service cost	3,000,000	3,000,000		11,000,000	9,000,000
Interest cost	7,000,000	6,000,000		22,000,000	22,000,000
Expected return on plan assets	(7,000,000)	(5,000,000)		(20,000,000)	(14,000,000)
Amortization of actuarial losses (gains)	2,000,000	1,000,000		4,000,000	3,000,000
Net periodic benefit cost	5,000,000	5,000,000		17,000,000	20,000,000
Other postretirement charges	0	0		0	0
ERISA litigation matter				0	0
Total pension cost	$ 5,000,000	$ 5,000,000		$ 17,000,000	$ 20,000,000

Contingencies (Details) $ in Millions	1 Months Ended			3 Months Ended		9 Months Ended
Contingencies (Details) $ in Millions	Aug. 31, 2024 claim	Nov. 30, 2023 claim	Apr. 30, 2019 USD ($)	Sep. 30, 2024 USD ($) countryAndTerritory case	Mar. 31, 2023 USD ($)	Sep. 30, 2024 USD ($) countryAndTerritory lawsuit case	Sep. 30, 2023 USD ($)	Jun. 30, 2024 case	Dec. 31, 2023 case	Jul. 31, 2017 USD ($)	Dec. 31, 2005 USD ($)
Loss Contingencies [Line Items]
Number of countries in which entity operates (more than) \| countryAndTerritory				200		200
Brazilian internal revenue authority, matter 1				$ 105.0		$ 105.0
Loss contingency, number of cases pending in lower federal count \| lawsuit						3
Loss contingency, number of cases on appeal \| case						2
Loss contingency, number of petitions to remove penalty portion of the claim \| claim		3
Loss contingency, number of petitions approved for reduced penalty portion of the claim \| claim	2
Brazilian internal revenue authority, matter 2											$ 53.0
Fine imposed by Greek competition authority										$ 11.0
Increase (decrease) in fine imposed by Greek competition authority			$ 10.5
Loss contingency, pending claims, number (in cases) \| case				313		313		293	279
Loss contingency, new claims filed, number (in cases) \| case				39		105
Loss contingency, claims dismissed or settled, number (in cases) \| case				18		70
Loss contingency, number of cases removed from the case count \| case				1		1
Loss contingency, cases reaching jury verdict, number \| case				1
ERISA litigation matter					$ 267.0	$ 0.0	$ 267.0
Minimum
Loss Contingencies [Line Items]
Range of reasonably possible losses				$ 0.0		0.0
Maximum
Loss Contingencies [Line Items]
Range of reasonably possible losses				$ 275.0		$ 275.0

Segment Information

9 Months Ended

Sep. 30, 2024

Segment Reporting [Abstract]

Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition.

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

In connection with management changes, the Company realigned the reporting structure of its skin health business effective July 1, 2024. Accordingly, commencing with the quarter ended September 30, 2024, the results of the skin health business previously reported within the Europe reportable operating segment are reported with the other skin health businesses in the North America reportable operating segment, with no impact on the Company's consolidated results of operations or financial position. The Company has recast its historical geographic segment information to conform to the new reporting structure.

As a result of this reporting structure realignment, the Company reallocated the goodwill of its skin health business (approximately $223) from the Europe segment to the North America segment. In conjunction with this reporting structure realignment, the Company completed an assessment indicating no goodwill impairment existed as a result of this new segment reporting structure.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Intercompany sales have been eliminated. Corporate

operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Net sales by segment were as follows:


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2024		2023		2024		2023
Net sales
Oral, Personal and Home Care
North America	$	1,004	$	1,025	$	3,076	$	3,044
Latin America	1,156		1,194		3,676		3,447
Europe	744		690		2,102		1,935
Asia Pacific	725		682		2,133		2,084
Africa/Eurasia	278		266		827		822
Total Oral, Personal and Home Care	3,907		3,857		11,814		11,332
Pet Nutrition	1,126		1,058		3,342		3,175
Total Net sales	$	5,033	$	4,915	$	15,156	$	14,507

Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).

The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2024		2023		2024		2023
Net sales
Oral Care	44	%	43	%	43	%	42	%
Personal Care	18	%	19	%	18	%	19	%
Home Care	16	%	17	%	17	%	17	%
Pet Nutrition	22	%	21	%	22	%	22	%
Total Net sales	100	%	100	%	100	%	100	%

Operating profit by segment was as follows:


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2024		2023		2024		2023
Operating profit
Oral, Personal and Home Care
North America	$	206	$	227	$	633	$	640
Latin America	365		372		1,187		1,050
Europe	181		165		502		422
Asia Pacific	199		193		602		564
Africa/Eurasia	65		66		195		196
Total Oral, Personal and Home Care	1,016		1,024		3,119		2,873
Pet Nutrition	258		201		691		575
Corporate	(208)		(196)		(605)		(536)
Total Operating profit	$	1,065	$	1,029	$	3,205	$	2,912

Note: Table may not sum due to rounding.

Corporate Operating profit (loss) for the three months ended September 30, 2024 and September 30, 2023 included charges resulting from the 2022 Global Productivity Initiative of $15 and $2, respectively.

Corporate Operating profit (loss) for the nine months ended September 30, 2024 included charges resulting from the 2022 Global Productivity Initiative of $77.

Corporate Operating profit (loss) for the nine months ended September 30, 2023 included product recall costs of $25 and charges resulting from the 2022 Global Productivity Initiative of $25.

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/280/tableOfContent

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Fair Value Measurements and Financial Instruments

Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net income attributable to Colgate-Palmolive Company
Basic EPS	$ 737	$ 708	$ 2,150	$ 1,582
Diluted EPS	$ 737	$ 708	$ 2,150	$ 1,582
Shares (millions)
Basic EPS (in shares)	817.7	825.6	820.1	828.8
Stock options and restricted stock units (in shares)	4.8	1.7	4.1	1.7
Diluted EPS (in shares)	822.5	827.3	824.2	830.5
Per Share
Basic EPS (in dollars per share)	$ 0.90	$ 0.86	$ 2.62	$ 1.91
Diluted EPS (in dollars per share)	$ 0.90	$ 0.86	$ 2.61	$ 1.90

Fair Value Measurements and Financial Instruments

9 Months Ended

Sep. 30, 2024

Fair Value Disclosures [Abstract]

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged.

The Company’s derivative instruments include forward-starting interest rate swaps, foreign currency contracts and commodity contracts. The Company utilizes forward-starting interest rate swaps to mitigate the risk of variability in interest rate for future debt issuances and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, option contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.


	Assets					Liabilities
	Account	Fair Value					Account		Fair Value
Designated derivative instruments		September 30, 2024		December 31, 2023						September 30, 2024		December 31, 2023




Foreign currency contracts	Other current assets	$	31	$	19			Other accruals		$	39	$	25

Commodity contracts	Other current assets	—		—				Other accruals		1		1
Total designated		$	31	$	19					$	40	$	26

Other financial instruments
Marketable securities	Other current assets	$	260	$	179
Total other financial instruments		$	260	$	179

The carrying amount of cash, cash equivalents, marketable securities, accounts receivable and short-term debt approximated fair value as of September 30, 2024 and December 31, 2023. The estimated fair value of the Company’s long-term debt, including the current portion, as of September 30, 2024 and December 31, 2023, was $7,565 and $7,862, respectively, and the related carrying value was $7,929 and $8,239, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

The following tables present the notional values as of:


	September 30, 2024
	Foreign Currency Contracts		Foreign Currency Debt		Commodity Contracts		Total
Fair Value Hedges	$	1,732	$	—	$	—	$	1,732
Cash Flow Hedges	1,022		—		26		1,048
Net Investment Hedges	474		4,269		—		4,743


	December 31, 2023
	Foreign Currency Contracts		Foreign Currency Debt		Commodity Contracts		Total
Fair Value Hedges	$	1,625	$	—	$	—	$	1,625
Cash Flow Hedges	869		—		39		908
Net Investment Hedges	280		3,908		—		4,188

The amount of gain (loss) recognized in income associated with fair value hedges did not have a material impact on the Company’s Condensed Consolidated Financial Statements during the three and nine months ended September 30, 2024.

The amount of gain (loss) recognized in income and Accumulated Other Comprehensive Income (AOCI) associated with cash flow hedges did not have a material impact on the Company’s Condensed Consolidated Financial Statements during the three and nine months ended September 30, 2024.

The following table presents the amount of gain (loss) on net investment hedges recognized in the Company’s AOCI:


	Gain (Loss) Recognized in AOCI
	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Hedging instruments:
Foreign currency contracts	$	(4)	$	(37)	$	20	$	(19)
Foreign currency debt	(216)		50		(82)		90
Total gain (loss) on net investment hedges	$	(220)	$	13	$	(62)	$	71

Earnings Per Share

9 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Earnings Per Share

For the three months ended September 30, 2024 and 2023, earnings per share were as follows:


	Three Months Ended
	September 30, 2024					September 30, 2023
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	737	817.7	$	0.90	$	708	825.6	$	0.86
Stock options and restricted stock units			4.8					1.7
Diluted EPS	$	737	822.5	$	0.90	$	708	827.3	$	0.86

For the three months ended September 30, 2024 and 2023, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 315,441 and 13,538,153, respectively.

For the nine months ended September 30, 2024 and 2023, earnings per share were as follows:


	Nine Months Ended
	September 30, 2024					September 30, 2023
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	2,150	820.1	$	2.62	$	1,582	828.8	$	1.91
Stock options and restricted stock units			4.1					1.7
Diluted EPS	$	2,150	824.2	$	2.61	$	1,582	830.5	$	1.90

For the nine months ended September 30, 2024 and 2023, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 113,356 and 13,504,588, respectively.

Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in the number of shares outstanding during the year and rounding, the sum of the quarters’ earnings per share may not necessarily equal the earnings per share for any year-to-date period.

Condensed Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Net sales	$ 5,033	$ 4,915	$ 15,156	$ 14,507
Cost of sales	1,959	2,038	5,977	6,131
Gross profit	3,074	2,877	9,179	8,376
Selling, general and administrative expenses	1,979	1,822	5,833	5,348
Other (income) expense, net	30	26	141	116
Operating profit	1,065	1,029	3,205	2,912
Non-service related postretirement costs	23	15	67	338
Interest (income) expense, net	56	58	175	170
Income before income taxes	986	956	2,963	2,404
Provision for income taxes	210	209	693	709
Net income including noncontrolling interests	776	747	2,270	1,695
Less: Net income attributable to noncontrolling interests	39	39	120	113
Net income attributable to Colgate-Palmolive Company	$ 737	$ 708	$ 2,150	$ 1,582
Earnings per common share, basic (in dollars per share)	$ 0.90	$ 0.86	$ 2.62	$ 1.91
Earnings per common share, diluted (in dollars per share)	$ 0.90	$ 0.86	$ 2.61	$ 1.90

Contingencies	9 Months Ended
Contingencies	Sep. 30, 2024
Loss Contingency [Abstract]
Contingencies	Contingencies As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. In addition, management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites. The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances. The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $275 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate range may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above. Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year. Brazilian Matters There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”). The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $105. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001. In each of September 2015, February 2017, September 2018, April 2019 and August 2020, the Company lost an administrative appeal and subsequently challenged these assessments in the Brazilian federal courts. Currently, there are three lawsuits pending in the Lower Federal Court and two cases have progressed to the Federal Court of Appeals. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously. In November 2023, based upon changes in Brazilian tax law, the Company filed petitions in three of the actions requesting that the penalty portion of the claim be removed. The Brazilian tax authority agreed with the Company's position and in August 2024 reduced its claim in two of those actions and in October 2024 reduced its claim in the third. In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously. In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $53, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously. In addition, in April 2024, based upon changes in Brazilian tax law, the Company filed a petition in this matter requesting that the penalty portion of the claim be removed. The Brazilian tax authority has not yet responded to that petition. Competition Matter Certain of the Company’s subsidiaries were historically subject to actions and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status as of September 30, 2024 of such competition law matters pending against the Company during the nine months ended September 30, 2024 is set forth below. ▪In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11. The Company appealed the decision to the Greek courts. In April 2019, the Greek courts affirmed the judgment against the Company’s Greek subsidiary, but reduced the fine to $10.5 and dismissed the case against Colgate-Palmolive Company. The Company’s Greek subsidiary and the Greek competition authority appealed the decision to the Greek Supreme Court. Talcum Powder Matters The Company has been named as a defendant in civil actions alleging that certain of its talcum powder products were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of September 30, 2024, there were 313 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 293 cases as of June 30, 2024 and 279 cases as of December 31, 2023. During the three months ended September 30, 2024, 39 new cases were filed, 18 cases were resolved by voluntary dismissal or settlement and one case was removed from the case count when it was established that the claim does not relate to talcum powder. During the nine months ended September 30, 2024, 105 new cases were filed and 70 cases were resolved by voluntary dismissal, settlement or dismissal by the court, and one case was removed from the case count as described in the previous sentence. The value of the settlements in the periods presented was not material, either individually or in the aggregate, to such periods’ results of operations. During the three months ended March 31, 2024, one case resulted in a jury verdict in favor of the Company after a trial. Subsequently, the trial court granted plaintiffs’ motion for a new trial in that case. However, during the three months ended September 30, 2024, an appellate court granted the Company’s request to reinstate the jury’s verdict in favor of the Company. Plaintiffs are challenging the ruling of the appellate court. A significant portion of the Company’s costs incurred in defending and resolving these claims has been, and the Company believes that a portion of the costs will continue to be, covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions, policy limits and insurance carrier insolvencies. While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. ERISA Matter In June 2016, a lawsuit was filed in the United States District Court for the Southern District of New York (the “District Court”) against the Retirement Plan, the Company and certain individuals (the “Company Defendants”) claiming that residual annuity payments associated with a 2005 residual annuity amendment to the Retirement Plan were improperly calculated for certain Retirement Plan participants in violation of ERISA. The relief sought included recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. This action was certified as a class action in July 2017. In July 2020, the District Court dismissed certain claims, and in August 2020 granted the plaintiffs’ motion for summary judgment on the remaining claims. In September 2020, the Company appealed to the Second Circuit. In March 2023, the Second Circuit affirmed the grant of summary judgment to the plaintiffs. In light of the Second Circuit decision, the Company recorded a charge to earnings of $267 in the quarter ended March 31, 2023, which is comprised of the recalculation of benefits and interest. Possible additional charges associated with this matter are expected to be immaterial and, where estimable, are reflected in the range of reasonably possible losses disclosed above. The decision resulted in an increase in the obligations of the Retirement Plan, which based on the current funded status of the Retirement Plan and depending on the asset performance, impact of interest rates for the remainder of the year and further developments in the litigation, may require a cash contribution by the Company in 2025. In June 2023, the Company filed a petition for certiorari to the United States Supreme Court requesting permission for an appeal to that court and that petition was denied in October 2023. Also, in June 2023, the plaintiffs filed a motion to enter a revised final judgment in the District Court to address certain unresolved calculation issues, which the Company opposed. In March 2024, the District Court granted the plaintiffs’ motion and found for the plaintiffs on those calculation issues. The Company is appealing that decision to the Second Circuit.

Basis of Presentation	9 Months Ended
Basis of Presentation	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Note that certain columns and rows may not sum due to rounding. Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) reclassifies certain prior year amounts, as applicable, to conform to the current year presentation. For a complete set of financial statement notes, including the Company’s significant accounting policies, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission (the “SEC”).

Supplier Finance Program	9 Months Ended
Supplier Finance Program	Sep. 30, 2024
Other Liabilities Disclosure [Abstract]
Supplier Finance Program	Supplier Finance Program The Company has agreements to provide supplier finance programs which facilitate participating suppliers’ ability to finance payment obligations of the Company with designated third-party financial institutions. Participating suppliers may, at their sole discretion, elect to finance one or more payment obligations of the Company prior to their scheduled due dates at a discounted price to participating financial institutions. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to finance amounts under these arrangements. The outstanding payment obligations under the Company’s supplier finance programs are included in Accounts Payable in the Condensed Consolidated Balance Sheets and were not material as of September 30, 2024 and December 31, 2023.

Retirement Plans and Other Retiree Benefits

9 Months Ended

Sep. 30, 2024

Retirement Benefits [Abstract]

Retirement Plans and Other Retiree Benefits

Components of Net periodic benefit cost for the three and nine months ended September 30, 2024 and 2023 were as follows:


	Three Months Ended September 30,
	Pension Benefits								Other Retiree Benefits
	United States				International
	2024		2023		2024		2023		2024		2023
Service cost	$	1	$	—	$	3	$	3	$	2	$	2
Interest cost	23		20		7		6		8		7
Expected return on plan assets	(20)		(20)		(7)		(5)		—		—
Amortization of actuarial losses (gains)	10		12		2		1		(5)		(6)
Net periodic benefit cost	$	14	$	12	$	5	$	5	$	5	$	3
Other postretirement charges	5		—		—		—		—		—


Total pension cost	$	19	$	12	$	5	$	5	$	5	$	3


	Nine Months Ended September 30,
	Pension Benefits								Other Retiree Benefits
	United States				International

	2024		2023		2024		2023		2024		2023
Service cost	$	1	$	—	$	11	$	9	$	6	$	6
Interest cost	70		68		22		22		26		29
Expected return on plan assets	(58)		(61)		(20)		(14)		—		—

Amortization of actuarial losses (gains)	31		34		4		3		(13)		(14)
Net periodic benefit cost	$	44	$	41	$	17	$	20	$	19	$	21
Other postretirement charges	5		4		—		—		—		—
ERISA litigation matter	—		267		—		—		—		—
Total pension cost	$	49	$	312	$	17	$	20	$	19	$	21

Other postretirement charges for the three and nine months ended September 30, 2024 included pension and other charges amounting to $5. Other postretirement charges for the three and nine months ended September 30, 2023 included pension and other charges of $0 and $4, respectively, incurred pursuant to the 2022 Global Productivity Initiative.

In the first quarter of 2023, the Company recorded a charge of $267 as a result of a decision of the United States Court of Appeals for the Second Circuit (the “Second Circuit”) affirming a grant of summary judgment to the plaintiffs in a lawsuit under the Employee Retirement Income Security Act (“ERISA”) seeking the recalculation of benefits and other relief associated with a 2005 residual annuity amendment to the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Retirement Plan”). The decision resulted in an increase in the obligations of the Retirement Plan, which based on the current funded status of the Retirement Plan and depending on the asset performance, impact of interest rates for the remainder of the year and further developments in the litigation, may require a cash contribution by the Company in 2025. See Note 9, Contingencies for additional information.

For the three and nine months ended September 30, 2024 and 2023, the Company made no voluntary contributions to its U.S. postretirement plans.

The entire disclosure for retirement benefits.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 70
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480794/715-70-50-1

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480482/715-20-55-17

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (q)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (l)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/715/tableOfContent

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (o)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (p)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480126/715-20-S99-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 60
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480266/715-60-50-3

Schedule of Earnings Per Share, Basic and Diluted

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate (percent)	21.30%	21.90%
Effective income tax rate, full year (percent)			23.70%	23.70%
Estimated tax plus interest			$ 150
Cumulative effect of change in tax position		$ 148
Withholding tax reserves, prior year reversals		$ 22

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

For the three months ended September 30, 2024 and 2023, earnings per share were as follows:


	Three Months Ended
	September 30, 2024					September 30, 2023
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	737	817.7	$	0.90	$	708	825.6	$	0.86
Stock options and restricted stock units			4.8					1.7
Diluted EPS	$	737	822.5	$	0.90	$	708	827.3	$	0.86

For the nine months ended September 30, 2024 and 2023, earnings per share were as follows:


	Nine Months Ended
	September 30, 2024					September 30, 2023
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	2,150	820.1	$	2.62	$	1,582	828.8	$	1.91
Stock options and restricted stock units			4.1					1.7
Diluted EPS	$	2,150	824.2	$	2.61	$	1,582	830.5	$	1.90

Segment Information - Narrative (Details) $ in Millions	3 Months Ended		9 Months Ended
Segment Information - Narrative (Details) $ in Millions	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) segment	Sep. 30, 2023 USD ($)
Segment Reporting Information [Line Items]
Number of product segments (in segments) \| segment			2
Number of geographically reportable operating segments (in segments) \| segment			5
Goodwill transfers	$ 223
Corporate \| Included in Operating profit (loss) \| Global Productivity Initiative
Segment Reporting Information [Line Items]
Restructuring costs	$ 15	$ 2	$ 77	$ 25
Corporate \| Included in Operating profit (loss) \| Product Recall Cost
Segment Reporting Information [Line Items]
Restructuring costs				$ 25
Net Sales
Segment Reporting Information [Line Items]
Percentage of consolidated Net sales represented by sales outside US	66.67%		66.67%
Percentage of consolidated Net sales coming from emerging markets	45.00%		45.00%

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating Activities
Net income including noncontrolling interests	$ 2,270	$ 1,695
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	457	417
ERISA litigation matter	0	267
Restructuring and termination benefits, net of cash	54	(17)
Stock-based compensation expense	108	97
Deferred income taxes	(98)	(109)
Cash effects of changes in:
Receivables	(184)	(62)
Inventories	(94)	150
Accounts payable and other accruals	327	168
Other non-current assets and liabilities	(2)	3
Net cash provided by (used in) operations	2,838	2,609
Investing Activities
Capital expenditures	(377)	(508)
Purchases of marketable securities and investments	(358)	(324)
Proceeds from sale of marketable securities and investments	260	264
Other investing activities	21	(31)
Net cash provided by (used in) investing activities	(454)	(599)
Financing Activities
Short-term borrowing (repayment) less than 90 days, net	337	(564)
Principal payments of debt	(502)	(903)
Proceeds from issuance of debt	2	1,497
Dividends paid	(1,275)	(1,243)
Purchases of treasury shares	(1,284)	(883)
Proceeds from exercise of stock options	611	325
Other financing activities	1	(30)
Net cash provided by (used in) financing activities	(2,110)	(1,801)
Effect of exchange rate changes on Cash and cash equivalents	(6)	(33)
Net increase (decrease) in Cash and cash equivalents	268	176
Cash and cash equivalents at beginning of the period	966	775
Cash and cash equivalents at end of the period	1,234	951
Supplemental Cash Flow Information
Income taxes paid	762	726
Interest paid	$ 267	$ 243

Other Comprehensive Income (Loss) - Schedule of Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Total Other comprehensive income (loss), net of tax

$ 58

$ (42)

$ (141)

$ 37

Accumulated Other Comprehensive Income (Loss)

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Total Other comprehensive income (loss), net of tax

^[1]

(39)

^[1]

(136)

^[2]

Cumulative translation adjustments, pre-tax

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Other comprehensive income (loss), before tax

(10)

(46)

(175)

Other comprehensive income (loss), pretax

(10)

(46)

(175)

Tax amounts

(30)

(25)

Total Other comprehensive income (loss), net of tax

(76)

(163)

Retirement Plan and other retiree benefit adjustments, net of tax

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Other comprehensive income (loss), before tax

Other comprehensive income (loss), before reclassifications, pretax

Reclassification from AOCI, pretax

Other comprehensive income (loss), pretax

Tax amounts

(8)

(15)

(11)

(18)

Total Other comprehensive income (loss), net of tax

Gains (losses) on cash flow hedges, net of tax

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Other comprehensive income (loss), before tax

(8)

(6)

Other comprehensive income (loss), pretax

(8)

(6)

Tax amounts

(2)

Total Other comprehensive income (loss), net of tax

$ (7)

$ 5

$ (5)

$ 1

[1]

Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,515 at September 30, 2024 ($3,458 at September 30, 2023) and $3,555 at June 30, 2024 ($3,381 at June 30, 2023), respectively, and unrecognized retirement plan and other retiree benefits costs of $615 at September 30, 2024 ($586 at September 30, 2023) and $636 at June 30, 2024 ($618 at June 30, 2023), respectively.

[2]

Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,515 at September 30, 2024 ($3,458 at September 30, 2023) and $3,351 at December 31, 2023 ($3,491 at December 31, 2022), respectively, and unrecognized retirement plan and other retiree benefits costs of $615 at September 30, 2024 ($586 at September 30, 2023) and $647 at December 31, 2023 ($631 at December 31, 2022), respectively.

Restructuring and Related Implementation Charges

9 Months Ended

Sep. 30, 2024

Restructuring and Related Activities [Abstract]

Restructuring and Related Implementation Charges

On January 27, 2022, the Company’s Board of Directors (the “Board”) approved a targeted productivity program (the “2022 Global Productivity Initiative”). All initiatives under the program have been implemented as of the third quarter of 2024 and the Company expects to incur the remaining charges by the end of 2024. The 2022 Global Productivity Initiative resulted in the reallocation of resources towards the Company’s strategic priorities and faster growth businesses, efficiencies in the Company’s operations and the streamlining of its supply chain to reduce structural costs.

Total pretax charges from the implementation of the 2022 Global Productivity Initiative are expected to be approximately $225 ($180 aftertax), once all the charges are recorded, which is comprised of the following categories: employee-related costs, including severance, pension and other termination benefits (80%); asset-related costs, primarily accelerated depreciation and asset write-downs (5%); and other charges (15%), which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities and the implementation of new strategies. It is expected that approximately 80% of the charges will result in cash expenditures.

For the three months ended September 30, 2024, charges resulting from the 2022 Global Productivity Initiative were $15 pretax ($13 aftertax). For the three months ended September 30, 2023, charges resulting from the 2022 Global Productivity Initiative were $2 pretax ($2 aftertax).

For the nine months ended September 30, 2024 and September 30, 2023, charges resulting from the 2022 Global Productivity Initiative are reflected in the income statement as follows:


	Nine Months Ended September 30,
	2024		2023
Gross Profit	$	19	$	1
Selling, general and administrative expenses	4		2
Other (income) expense, net	54		22
Non-service related postretirement costs	—		4
Total 2022 Global Productivity Initiative charges, pretax	$	77	$	29

Total 2022 Global Productivity Initiative charges, aftertax	$	67	$	23

Restructuring and related implementation charges were recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.

Total charges incurred for the 2022 Global Productivity Initiative relate to initiatives undertaken by the following reportable operating segments and Corporate:


	Nine Months Ended September 30,				Program-to-date Accumulated Charges
	2024		2023
North America(1)	3	%	15	%	9	%
Latin America	—	%	1	%	9	%
Europe(1)	88	%	19	%	43	%
Asia Pacific	—	%	21	%	7	%
Africa/Eurasia	—	%	10	%	6	%
Hill's Pet Nutrition	7	%	14	%	12	%
Corporate	2	%	20	%	14	%
Total	100	%	100	%	100	%


	Cumulative Charges
	as of September 30, 2024
Employee-Related Costs	$	175
Incremental Depreciation	13
Asset Impairments	1
Other	31
Total	$	220

The following table summarizes the activity for the restructuring and related implementation charges discussed above and the related accruals:


	Nine Months Ended September 30, 2024
	Employee-Related Costs		Incremental Depreciation		Asset Impairments		Other		Total
Balance at December 31, 2023	$	10	$	—	$	—	$	1	$	11
Charges	49		13		—		15		77
Cash Payments	(13)		—		—		(10)		(23)
Charges against assets	—		(13)		—		—		(13)
Foreign exchange	(1)		—		—		—		(1)
Balance at September 30, 2024	$	45	$	—	$	—	$	6	$	51

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, written severance policies, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension enhancements which are reflected as Charges against assets within Employee-Related Costs in the preceding table as the corresponding balance sheet amounts are

reflected as a reduction of pension assets or an increase in pension liabilities. For the nine months ended September 30, 2024, there were no pension enhancements included in Charges against assets within Employee-Related Costs.

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down inventories and assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Inventories (Tables)

9 Months Ended

Sep. 30, 2024

Inventory, Net, Items Net of Reserve Alternative [Abstract]

Schedule of Inventories by Major Class

Inventories by major class were as follows:


	September 30, 2024		December 31, 2023
Raw materials and supplies	$	620	$	606
Work-in-process	49		46
Finished goods	1,489		1,411
Total Inventories, net	$	2,158	$	2,063
Non-current inventory, net	(117)		(129)
Current Inventories, net	$	2,041	$	1,934

Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Fair Value Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	$ 1,732	$ 1,625
Fair Value Hedges \| Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	1,732	1,625
Fair Value Hedges \| Foreign Currency Debt
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	0	0
Fair Value Hedges \| Commodity Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	0	0
Cash Flow Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	1,048	908
Cash Flow Hedges \| Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	1,022	869
Cash Flow Hedges \| Foreign Currency Debt
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	0	0
Cash Flow Hedges \| Commodity Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	26	39
Net Investment Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	4,743	4,188
Net Investment Hedges \| Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	474	280
Net Investment Hedges \| Foreign Currency Debt
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	4,269	3,908
Net Investment Hedges \| Commodity Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	$ 0	$ 0

Cover Page	9 Months Ended
Cover Page	Sep. 30, 2024 shares
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	1-644
Entity Registrant Name	COLGATE-PALMOLIVE COMPANY
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	13-1815595
Entity Address, Address Line One	300 Park Avenue
Entity Address, City or Town	New York,
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022
City Area Code	212
Local Phone Number	310-2000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	817,010,957
Entity Central Index Key	0000021665
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Amendment Flag	false
Common Stock, $1.00 par value
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, $1.00 par value
Trading Symbol	CL
Security Exchange Name	NYSE
0.500% Notes due 2026
Entity Information [Line Items]
Title of 12(b) Security	0.500% Notes due 2026
Trading Symbol	CL26
Security Exchange Name	NYSE
0.300% Notes due 2029
Entity Information [Line Items]
Title of 12(b) Security	0.300% Notes due 2029
Trading Symbol	CL29
Security Exchange Name	NYSE
1.375% Notes due 2034
Entity Information [Line Items]
Title of 12(b) Security	1.375% Notes due 2034
Trading Symbol	CL34
Security Exchange Name	NYSE
0.875% Notes due 2039
Entity Information [Line Items]
Title of 12(b) Security	0.875% Notes due 2039
Trading Symbol	CL39
Security Exchange Name	NYSE

Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) - Net Investment Hedges - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net investment hedges [Abstract]
Total gain (loss) on net investment hedges	$ (220)	$ 13	$ (62)	$ 71
Foreign currency contracts
Net investment hedges [Abstract]
Total gain (loss) on net investment hedges	(4)	(37)	20	(19)
Foreign Currency Debt
Net investment hedges [Abstract]
Total gain (loss) on net investment hedges	$ (216)	$ 50	$ (82)	$ 90

Earnings Per Share - Narrative (Details) - shares	3 Months Ended		9 Months Ended
Earnings Per Share - Narrative (Details) - shares	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Antidilutive securities excluded from computation of earnings per share (in shares)	315,441	13,538,153	113,356	13,504,588

Restructuring and Related Implementation Charges - Schedule of Restructuring Charges Incurred, by Segment (Details) - Global Productivity Initiative	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	100.00%	100.00%
Program-to-date Accumulated Charges	100.00%
Hill's Pet Nutrition
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	7.00%	14.00%
Program-to-date Accumulated Charges	12.00%
Corporate
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	2.00%	20.00%
Program-to-date Accumulated Charges	14.00%
North America
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	3.00%	15.00%
Program-to-date Accumulated Charges	9.00%
Latin America
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	0.00%	1.00%
Program-to-date Accumulated Charges	9.00%
Europe
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	88.00%	19.00%
Program-to-date Accumulated Charges	43.00%
Asia Pacific
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	0.00%	21.00%
Program-to-date Accumulated Charges	7.00%
Africa/Eurasia
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	0.00%	10.00%
Program-to-date Accumulated Charges	6.00%

Other Comprehensive Income (Loss)

9 Months Ended

Sep. 30, 2024

Equity [Abstract]

Other Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three and nine months ended September 30, 2024 and 2023 were as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Cumulative translation adjustments, pre-tax	$	(10)	$	(46)	$	(175)	$	60
Tax amounts	51		(30)		12		(25)
Cumulative translation adjustments, net of tax	41		(76)		(163)		35
Pension and other benefits:
Net actuarial gains (losses), prior service costs and settlements during the period	22		40		21		40
Amortization of net actuarial losses (gains), transition and prior service costs(1)	7		7		22		23

Retirement Plan and other retiree benefit adjustments, pre-tax	29		47		43		63





Tax amounts	(8)		(15)		(11)		(18)
Retirement Plan and other retiree benefit adjustments, net of tax	21		32		32		45
Cash flow hedges:


Gains (losses) on cash flow hedges, pre-tax	(8)		7		(6)		1
Tax amounts	1		(2)		1		—
Gains (losses) on cash flow hedges, net of tax	(7)		5		(5)		1
Total Other comprehensive income (loss), net of tax	$	55	$	(39)	$	(136)	$	81

(1) These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 8, Retirement Plans and Other Retiree Benefits for additional details.

There were no tax impacts on Other comprehensive income (loss) (“OCI”) attributable to Noncontrolling interests.

Other Comprehensive Income (Loss) (Tables)

9 Months Ended

Sep. 30, 2024

Equity [Abstract]

Schedule of Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three and nine months ended September 30, 2024 and 2023 were as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Cumulative translation adjustments, pre-tax	$	(10)	$	(46)	$	(175)	$	60
Tax amounts	51		(30)		12		(25)
Cumulative translation adjustments, net of tax	41		(76)		(163)		35
Pension and other benefits:
Net actuarial gains (losses), prior service costs and settlements during the period	22		40		21		40
Amortization of net actuarial losses (gains), transition and prior service costs(1)	7		7		22		23

Retirement Plan and other retiree benefit adjustments, pre-tax	29		47		43		63





Tax amounts	(8)		(15)		(11)		(18)
Retirement Plan and other retiree benefit adjustments, net of tax	21		32		32		45
Cash flow hedges:


Gains (losses) on cash flow hedges, pre-tax	(8)		7		(6)		1
Tax amounts	1		(2)		1		—
Gains (losses) on cash flow hedges, net of tax	(7)		5		(5)		1
Total Other comprehensive income (loss), net of tax	$	55	$	(39)	$	(136)	$	81

(1) These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 8, Retirement Plans and Other Retiree Benefits for additional details.

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Current Assets
Allowance for doubtful accounts receivable, current	$ 88	$ 80
Shareholders’ Equity
Common stock par value (in dollars per share)	$ 1	$ 1
Common stock authorized (in shares)	2,000,000,000	2,000,000,000
Common stock issued (in shares)	1,465,706,360	1,465,706,360

Fair Value Measurements and Financial Instruments - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Derivative, term of contract	12 months
Carrying Value
Debt Instrument [Line Items]
Carrying value of long-term debt	$ 7,929	$ 8,239
Fair Value, Inputs, Level 2
Debt Instrument [Line Items]
Estimated fair value of long-term debt	$ 7,565	$ 7,862

Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-10

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 55
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482949/835-30-55-8

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(f))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69F
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482900/835-30-50-1